GRK2 and arthritic joint disease: Of note, no changes of GRK2 mRNA levels were observed either in PBMCs of RA patients or in rat splenocytes during adjuvant arthritis, suggesting that the observed down-regulation of GRK2 associated with arthritis involves a process of posttranscriptional modification and/or protein degradation [12,22].